logo

Brainstorm Cell Therapeutics, Inc. (BCLI) Stock: A Comprehensive 52-Week Review

CROX

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Brainstorm Cell Therapeutics, Inc.’s current trading price is -78.36% away from its 52-week high, while its distance from the 52-week low is 444.78%. The stock’s price range over this period has fluctuated between $0.13 and $3.37. The company, operating within the financial sector, had a trading volume of approximately 1.04 million for the day, which was noticeably higher than the average daily share volume of 0.96 million over the last 3 months.

In terms of market performance, Brainstorm Cell Therapeutics, Inc. had a fairly uneven. The highest value for the stock in the past year was $3.37 on 04/24/23, and the lowest value was recorded at $0.13 on 10/31/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly rise of 156.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 49.89M and boasts a workforce of 29 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3407, with a change in price of +0.5596. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 2,072,092 in trading volume during the last 100 days, posting a change of +328.40%.

BCLI Stock Stochastic Average

Today’s raw stochastic average for Brainstorm Cell Therapeutics, Inc. over the last 50 days is 88.00%.This indicates a increase from the raw stochastic average of the past 20 days, which was 88.00%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 79.46% and 79.17%, respectively.

BCLI Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 167.40%. However, over the past six months, we’ve seen a weaker performance of 303.31%. The price of BCLI fallen by 109.83% over the last 30 days. And in the last five days, it has fallen by -1.34%.